Carboplatin versus etoposide/cisplatin for advanced metastatic seminoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN27827390

Enrollment

112

Registered

2001-02-28

Start date

1990-08-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer Testicular

Interventions

Arm 1 - 4 cycles of carboplatin. Arm 2 - 4 cycles of cisplatin/etoposide.

Eligibility

Inclusion criteria

Inclusion criteria: Histologically verified testicular/extra-gonadal pure seminoma

Exclusion criteria

Exclusion criteria: Previous chemotherapy.

Design outcomes

Primary

Measure	Time frame
Progression-free survival	—

Secondary

Measure	Time frame
Response, survival, toxicity.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026